Mounjaro on HealthSpring Assurance Rx (S5617-216)
tirzepatide injection
Covered, with prior authorization required.
Tier 3 (preferred brand). Quantity limit of 2 per 28 days.
$232.36
Patient pays / month, after deductible
$712.06
Patient pays / month, before the $615.00 deductible
$697.09
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
MOUNJARO 15 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,056.20 for a month. Other covered strengths are listed below.
Prior authRequired on all 6 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 6 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| MOUNJARO 15 mg/.5mL Injection, Solution | 3 | $232.36 | PA · 2 per 28 days |
| MOUNJARO 12.5 mg/.5mL Injection, Solution | 3 | $233.24 | PA · 2 per 28 days |
| MOUNJARO 10 mg/.5mL Injection, Solution | 3 | $233.09 | PA · 2 per 28 days |
| MOUNJARO 7.5 mg/.5mL Injection, Solution | 3 | $233.07 | PA · 2 per 28 days |
| MOUNJARO 5 mg/.5mL Injection, Solution | 3 | $233.50 | PA · 2 per 28 days |
| MOUNJARO 2.5 mg/.5mL Injection, Solution | 3 | $233.85 | PA · 2 per 28 days |
Other GLP-1s on this plan
Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5617-216